Insider Activity of Flanagan W. Michael
According to the SEC Form 4 filings, Flanagan W. Michael, being in a position of
- Chief Scientific Officer at Atrium Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 8907 shares for $644,790,over all time since 2024-01-22, has bought 0 shares, and sold 336230 shares for $13.5M.
Biography of Flanagan W. Michael
No biography is available at this moment.